[HTML][HTML] Patient-reported outcomes during and after hepatitis C virus direct-acting antiviral treatment among people who inject drugs

Q Cheng, EB Cunningham, S Shih, J Amin, J Bruneau… - Value in Health, 2023 - Elsevier
Objectives People who inject drugs (PWID) are at a high risk of hepatitis C virus (HCV)
infection. HCV cure is associated with improved patient-reported outcomes (PROs), but …

Improved health‐related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durable

SA McDonald, G Myring, NE Palmateer, A McAuley… - …, 2023 - Wiley Online Library
Abstract Background and Aims Chronic infection with the hepatitis C virus (HCV) has a
detrimental impact on health‐related quality of life (QoL). Scale‐up of HCV direct‐acting …

Changes in health-related quality of life for hepatitis C virus–infected people who inject drugs while on opioid agonist treatment following sustained virologic response

MA Gormley, MJ Akiyama, L Rennert… - Clinical Infectious …, 2022 - academic.oup.com
Background Although efforts to treat hepatitis C virus (HCV) in people who inject drugs
(PWID) yield high rates of sustained virologic response (SVR), the relationship between …

Patient‐reported outcomes of the Treatment and Prevention Study: A real‐world community‐based trial of direct‐acting antivirals for hepatitis C among people who …

S Goutzamanis, T Spelman, B Harney… - Journal of Viral …, 2021 - Wiley Online Library
The impact of hepatitis C cure with direct‐acting antivirals (DAAs) on patient‐reported
outcomes (PROs) in community settings remains unclear. We aimed to assess changes in …

Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study

Q Cheng, H Valerio, EB Cunningham, STF Shih, D Silk… - Value in Health, 2024 - Elsevier
Objectives There is limited research on health-related quality of life (HRQoL) among people
who inject drugs (PWID). We evaluated the HRQoL and associated factors among a cohort …

“Stigma is where the harm comes from”: exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs

T Goodyear, H Brown, AJ Browne, P Hoong, L Ti… - International Journal of …, 2021 - Elsevier
Background The advent of direct-acting antiviral (DAA) medications has facilitated
opportunities to treat hepatitis C virus (HCV) among people who inject drugs (PWID) …

Real-world efficacy of direct-acting antiviral therapy for HCV infection affecting people who inject drugs delivered in a multidisciplinary setting

A Alimohammadi, J Holeksa, A Thiam… - Open forum …, 2018 - academic.oup.com
Background Many clinicians and insurance providers are reluctant to embrace recent
guidelines identifying people who inject drugs (PWID) as a priority population to receive …

Beyond clinical outcomes: the social and healthcare system implications of hepatitis C treatment

M Torrens, T Soyemi, D Bowman, E Schatz - BMC infectious diseases, 2020 - Springer
Abstract Background Hepatitis C virus (HCV) infections in people who inject drugs (PWID)
can now be treated and cured. However, the impact that HCV treatment has on drug-user …

Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland

SA McDonald, SJ Hutchinson, NE Palmateer… - Journal of …, 2013 - Elsevier
BACKGROUND & AIMS: Chronic hepatitis C virus (HCV) infection can significantly reduce
health-related quality of life (QoL), but it is not clear if reduction is associated with the …

Quality of life and social functioning during treatment of recent hepatitis C infection: a multi-centre prospective cohort

JS Doyle, J Grebely, T Spelman, M Alavi… - PLoS …, 2016 - journals.plos.org
Aim Despite effective treatment for recent hepatitis C (HCV) infection, side-effects and
adherence concerns limit its use among people who inject drugs (PWID). This study …